全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Prevalence of Hyperuricemia in the Cardiology Department of the Gabriel Touré University Hospital

DOI: 10.4236/wjcd.2026.166047, PP. 490-497

Keywords: Uric Acid, Hyperuricemia, Cardiovascular Risk Factor, Gabriel Touré University Hospital, Bamako

Full-Text   Cite this paper   Add to My Lib

Abstract:

Uric acid (UA) is considered a true cardiovascular risk factor. Hyperuricemia is defined as a serum UA concentration > 70 mg/L or 420 μmol/L and occurs when UA production exceeds its excretion. The objective of our study was to investigate hyperuricemia in the cardiology department of the Gabriel Touré University Hospital. Methods: This was a descriptive and analytical cross-sectional study conducted over a 3-month period from May 1 to July 31, 2025, in the cardiology department of the Gabriel Touré University Hospital in Bamako. It included all patients aged 17 years or older who were seen in consultation and/or hospitalized and who consented to participate in the study. Patients who were unable to undergo serum uric acid testing were excluded. Data collection was carried out using a survey form including sociodemographic, clinical, and paraclinical data. Data entry and analysis were performed using SPSS version 25.0, and the chi-square test was used for statistical analysis. Results: During the study period, 629 patients were seen or hospitalized. Among them, 200 patients underwent serum uric acid testing, and 114 had hyperuricemia, representing a hospital frequency of 57%. The age group ≥ 60 years was the most represented (44%), and uric acid levels were higher in this group (47.4%), although the difference was not statistically significant (p = 0.707). Females were the most represented (67%; n = 134), with a male to female ratio of 0.49. Hyperuricemia was more frequent in women (60.5% vs. 39.5%; p = 0.025), with a statistically significant association between hyperuricemia and sex. Conclusion: The frequency of hyperuricemia is not negligible in our department, hypertension and sedentary lifestyle were highly prevalent cardiovascular risk factors in our population, and however, their association with hyperuricemia was not statistically significant.

References

[1]  Schlienger, J.-L. (2016) Hyperuricémie chronique: Facteur ou marqueur de risque cardio-métabolique? Médecine des Maladies Métaboliques, 10, 280-284.
https://doi.org/10.1016/s1957-2557(16)30070-0
[2]  Maesaka, J. and Fishbane, S. (1998) Regulation of Renal Urate Excretion: A Critical Review. American Journal of Kidney Diseases, 32, 917-933.
https://doi.org/10.1016/s0272-6386(98)70067-8
[3]  El Ridi, R. and Tallima, H. (2017) Physiological Functions and Pathogenic Potential of Uric Acid: A Review. Journal of Advanced Research, 8, 487-493.
https://doi.org/10.1016/j.jare.2017.03.003
[4]  Mijiyawa, M. and Bouglouga, O.E. (2003) Hyperuricémie et goutte en zone intertropicale. Revue du Rhumatisme, 70, 152-156.
https://doi.org/10.1016/s1169-8330(02)00029-7
[5]  El Aissaoui, M. (2014) L’hyperuricémie dans l’insuffisance cardiaque: Prévalence, physiopathologie et implications cliniques. Ph.D Thesis, Université Paris Descartes.
https://dumas.ccsd.cnrs.fr/dumas-01114526v1
[6]  Habak, N., Rouibah, N. and Chikouche, A. (2022) Prévalence de l’hyperuricémie chez les diabétiques de type 2. Prevalence of hyperuricemia in type 2 diabetics. Journal Algérien de Biochimie et de Génétique Médicales, 2, 18-27.
[7]  Kone, F., Touré, K.H., Kouassi, L., Acho, J.K., Yapa, G.S.K., Nzonzy, B.S.R., et al. (2024) Prevalence and Determinants of Hyperuricemia in Type 2 Diabetes Mellitus Health Research in Africa, 2, 64-68.
[8]  Lamine, B.M. (2020) Hyperuricemia and Type 2 Diabetes. Mouloud Mammeri University.
[9]  Hamidou Oumar, B., et al. (2015) Prevalence of Hyperuricemia (HU) in Arterial Hypertension. Science Journal of Clinical Medicine, 4, 76-79.
https://doi.org/10.11648/j.sjcm.20150404.12
[10]  Cécile, B. (2023) Mesure et analyse de la prévalence de l’hyperuricémie chez les patients adultes hospitalisés pour un infarctus du myocarde dans le service de cardiologie du centre hospitalier de brive-la-gaillarde de mai à novembre 2021. Ph.D. Thesis, Université de Limoges.
https://cdn.unilim.fr/files/theses-exercice/M20233121.pdf
[11]  Ogbera, A.O. and Azenabor, A.O. (2010) Hyperuricaemia and the Metabolic Syndrome in Type 2 DM. Diabetology & Metabolic Syndrome, 2, Article No. 24.
https://doi.org/10.1186/1758-5996-2-24
[12]  Doualla, M., Halle, M.P., Moutchia, J., Tegang, S. and Ashuntantang, G. (2018) Determinants of Hyperuricemia in Non-Dialysed Chronic Kidney Disease Patients in Three Hospitals in Cameroon. BMC Nephrology, 19, Article No. 169.
https://doi.org/10.1186/s12882-018-0959-5
[13]  Wang, J., Chen, R.-P., Lei, L., Song, Q.-Q., Zhang, R.-Y., Li, Y.-B., et al. (2013) Prevalence and Determinants of Hyperuricemia in Type 2 Diabetes Mellitus Patients with Central Obesity in Guangdong Province in China. Asia Pacific Journal of Clinical Nutrition, 22, 590-598.
[14]  Bruderer, S., Bodmer, M., Jick, S.S. and Meier, C.R. (2014) Use of Diuretics and Risk of Incident Gout: A Population‐Based Case-Control Study. Arthritis & Rheumatology, 66, 185-196.
https://doi.org/10.1002/art.38203
[15]  Zhang, Y., Neogi, T., Chen, C., Chaisson, C., Hunter, D.J. and Choi, H. (2014) Low-dose Aspirin Use and Recurrent Gout Attacks. Annals of the Rheumatic Diseases, 73, 385-390.
https://doi.org/10.1136/annrheumdis-2012-202589
[16]  Schils, R. and Krzesinski, J.-M. (2016) La vignette thérapeutique de l’étudiant—Hyperuricémie et risque potentiel de pathologie cardio-vasculaire et rénale. Revue Médicale de Liège, 71, 262-268.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133